Canada markets close in 2 hours 22 minutes

MabCure, Inc. (MBCI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
As of 01:39PM EDT. Market open.

MabCure, Inc.

21 Sparrow Circle
White Plains, NY 10605
United States
845 591 3144

Sector(s)Technology
IndustrySolar
Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Jehu Thomas Degerold HandChief Executive & Financial Officer and DirectorN/AN/A1957
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.

Corporate Governance

MabCure, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.